Fundraising FoxWestlake BioPartners
Venture capitalWestlake Village · 4 people tracked
Find your way into Westlake BioPartners
Sign up to see every warm intro you have to Westlake BioPartners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Westlake BioPartners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Westlake BioPartners is a venture fund manager based in Westlake Village. SEC filings show 1 venture fund on record, most recently Westlake BioPartners Fund III, L.P. ($450M offering) filed June 2023.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 4 people
from curated & public directories
What they invest in
from 3 of 3 portfolio companiesBiotech ×3Healthtech ×1
HQs:United States×2
Investments · 3 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 12 dated
Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.
BiotechEmeryville, US
Warner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)Peter Maag(Executive Officer, Director)in
Co-investorsBain Capital Life SciencesVida VenturesWestlake Village BioPartnersGilead SciencesInsight PartnersKleiner Perkins+3 more
AllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions.
BiotechNatick, US
Catherine Pearce(CEO & Founder)inDHSc(Founder)Justin R Thompson(Founder)in
Co-investorsVersant VenturesWestlake Village BioPartners
Oorja Bio is a biotechnology company developing therapies focused on fibrotic disease, aiming to repair, reverse, and remodel fibrosis.
BiotechHealthtech
Sujay Kango(Chief Executive Officer & Founder)inJanethe Pena(Chief Medical Officer & Founder)inConnie Coulomb(Chief Business Officer & Founder)in
Co-investorsAndreessen HorowitzWestlake Village BioPartnersKleiner Perkins
Exits · 1
1 IPOsKyverna TherapeuticsNASDAQ: KYTX
Portfolio news
latest coverage across their companies
Kyverna Therapeutics · biospace.com · Sep 3, 2026
Oorja Bio · finsmes.com · May 20, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Kyverna Therapeutics | 11.1% | $22.00 | Feb 2024 | $99.5M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- Where is Westlake BioPartners located?
- Westlake BioPartners is headquartered in Westlake Village, US.